BorgWarner
BWA NYSE Automotive Parts & Equipment Financials FY2016βFY2025
BorgWarner's revenue rose 1.6% to $14.3 billion in fiscal 2025. Its operating margin was 3.7%, down from 3.9% a year earlier. Free cash flow was $1.2 billion, up 65.8%. It paid out $627 million in dividends and buybacks, 53% of free cash flow. The diluted share count fell 3.7%.
What BorgWarner does
No business description yet.
- Legal name
- BORGWARNER INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000908255-26-000011
0000908255
Revenue and margins
BorgWarner had $14.3B of revenue in fiscal 2025, up 1.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β8.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2025, 8.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
BorgWarner returned $627M to shareholders in fiscal 2025, 53% of free cash flow. The diluted share count fell 3.7%.
Value BorgWarner yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.6B and divides by 216.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 27.1x Β· peers 22.0x Β· sector 17.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably BorgWarner can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.8B | $1.3B | $1.5B | $2.1B | $2.3B |
| Debt incl. finance leases | $4.3B | $4.1B | $3.7B | $4.1B | $3.9B |
| Net debt / EBITDA | 1.6x | 1.8x | 1.3x | 1.7x | 1.3x |
| Debt / equity | 0.6x | 0.6x | 0.6x | 0.7x | 0.7x |
| Interest coverage | 11.2x | 14.2x | 15.9x | 6.5x | 5.4x |
| Current ratio | 1.7x | 1.6x | 1.7x | 1.8x | 2.1x |
| Quick ratio | 1.3x | 1.3x | 1.3x | 1.5x | 1.7x |
| Total assets | $16.6B | $17.0B | $14.5B | $14.0B | $13.8B |
| Total liabilities | $9.3B | $9.5B | $8.4B | $8.3B | $8.2B |
| Shareholders' equity | $6.9B | $7.2B | $5.8B | $5.5B | $5.4B |
| Net debt (β = net cash) | $2.4B | $2.8B | $2.2B | $2.0B | $1.6B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.5M
1 insider
Sold, 12 months
$8.9M
9 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Michael S HanleyDirector | Sold | 5,000 | $65.51 | $0.3M | Form 4 |
| Aug 24, 2026 | Tonit M CalawayEVP, CAO, Gen Counsel & Sec | Sold | 22,000 | $66.26 | $1.5M | Form 4 |
| Aug 19, 2026 | Rajesh KalathurDirector | Bought | 7,407 | $67.59 | $0.5M | Form 4 |
| Aug 18, 2026 | Amy B. KulikowskiVP & Chief Accounting Officer | Sold | 2,900 | $68.60 | $0.2M | Form 4 |
| Aug 17, 2026 | Isabelle McKenzieVice President | Sold | 4,500 | $70.39 | $0.3M | Form 4 |
| Aug 17, 2026 | Shaun McAlmontDirector | Sold | 7,000 | $69.36 | $0.5M | Form 4 |
| Aug 17, 2026 | Stefan DemmerleVice President | Sold | 1,000 | $70.00 | $0.1M | Form 4 |
| Aug 17, 2026 | Tonit M CalawayEVP, CAO, Gen Counsel & Sec | Sold | 44,000 | $69.65 | $3.1M | Form 4 |
| Jun 5, 2026 | Sailaja ShankarDirector | Sold | 5,000 | $73.08 | $0.4M | Form 4 |
| May 28, 2026 | Volker WengVice President | Sold | 5,000 | $72.35 | $0.4M | Form 4 |
| May 14, 2026 | Volker WengVice President | Sold | 5,000 | $67.71 | $0.3M | Form 4 |
| May 13, 2026 | Joseph F. FadoolPresident and CEO, Director | Sold | 29,000 | $67.31 | $2.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 7 / 9 | 7 / 9 |
| Accruals ratio | β4.9% | β7.3% | β9.9% |
| Altman Z'' | 3.80 | 3.83 | 4.21 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| BorgWarner BWA | $11.3B | 1.6% | 3.7% | 8.2% | 4.6% | 27.1x | 7 | |
| Adient ADNT | $1.3B | β1.0% | β | 1.4% | 2.0% | 30.2x | 5 | Compare β |
| Autoliv ALV | $8.4B | 4.1% | 10.1% | 6.6% | 20.3% | 13.8x | 8 | Compare β |
| Aptiv APTV | $9.1B | 3.5% | 5.8% | 7.5% | 3.7% | 40.3x | 8 | Compare β |
| Lear LEA | $5.9B | β0.2% | 3.3% | 2.3% | 8.9% | 10.9x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $9.1B | $9.8B | $10.5B | $10.2B | $10.2B | $11.8B | $12.6B | $14.2B | $14.1B | $14.3B |
| Gross profit | $1.9B | $2.1B | $2.2B | $2.1B | $1.9B | $2.2B | $2.4B | $2.6B | $2.6B | $2.7B |
| Research and development | $343M | $408M | $440M | $413M | $476M | $586M | $701M | $717M | $736M | $710M |
| Operating income | $973M | $1.1B | $1.2B | $1.3B | $618M | $914M | $1.0B | $1.2B | $546M | $536M |
| Interest expense | $84.6M | $71.0M | $59.0M | $55.0M | $73.0M | $82.0M | $71.0M | $73.0M | $84.0M | $99.0M |
| Pretax income | $943M | $1.1B | $1.2B | $1.3B | $964M | $510M | $913M | $991M | $539M | $524M |
| Income tax | $306M | $580M | $211M | $468M | $397M | $65.0M | $195M | $289M | $111M | $189M |
| Net income | $595M | $440M | $931M | $746M | $500M | $537M | $944M | $625M | $338M | $277M |
| Diluted EPS | $2.76 | $2.08 | $4.44 | $3.61 | $2.34 | $2.24 | $3.99 | $2.67 | $1.50 | $1.28 |
| Diluted shares | 0.22B | 0.21B | 0.21B | 0.21B | 0.21B | 0.24B | 0.24B | 0.23B | 0.22B | 0.22B |
| Cash flow | ||||||||||
| Cash from operations | $1.0B | $1.2B | $1.1B | $1.0B | $1.2B | $1.3B | $1.6B | $1.4B | $1.4B | $1.6B |
| Capital expenditure | $501M | $560M | $546M | $481M | $441M | $514M | $622M | $832M | $671M | $469M |
| Free cash flow | $535M | $620M | $580M | $527M | $743M | $792M | $947M | $565M | $711M | $1.2B |
| Depreciation and amortization | $391M | $408M | $431M | $439M | $568M | $574M | $552M | $582M | $673M | $719M |
| Stock-based compensation | $43.6M | $52.0M | $53.0M | $42.0M | $41.0M | $50.0M | $64.0M | $58.0M | $62.0M | $66.0M |
| Acquisitions | $0.0M | $186M | $0.0M | $10.0M | $449M | $759M | $312M | $109M | $0.0M | $0.0M |
| Share buybacks | $288M | $100M | $150M | $100M | $216M | $0.0M | $240M | $177M | $402M | $508M |
| Dividends paid | $113M | $124M | $142M | $140M | $146M | $162M | $161M | $130M | $98.0M | $119M |
| Dividends and buybacks | $401M | $224M | $292M | $240M | $362M | $162M | $401M | $307M | $500M | $627M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $444M | $545M | $739M | $832M | $1.7B | $1.8B | $1.3B | $1.5B | $2.1B | $2.3B |
| Total debt | $2.1B | $2.1B | $2.1B | $1.9B | $3.7B | $4.3B | $4.1B | $3.7B | $4.1B | $3.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $14.0M | $13.0M | $12.0M | $26.0M | $23.0M | $18.0M |
| Current assets | $2.9B | $3.5B | $3.8B | $3.8B | $6.2B | $6.6B | $6.6B | $6.2B | $6.5B | $6.8B |
| Current liabilities | $2.1B | $2.4B | $2.4B | $2.3B | $3.8B | $3.8B | $4.2B | $3.8B | $3.6B | $3.3B |
| Inventory | $641M | $766M | $781M | $807M | $1.3B | $1.5B | $1.2B | $1.3B | $1.3B | $1.2B |
| Property and equipment, net | $2.5B | $2.9B | $2.9B | $2.9B | $4.6B | $4.4B | $3.4B | $3.8B | $3.6B | $3.3B |
| Total assets | $8.8B | $9.8B | $10.1B | $9.7B | $16.0B | $16.6B | $17.0B | $14.5B | $14.0B | $13.8B |
| Total liabilities | $5.5B | $6.0B | $5.8B | $4.9B | $9.3B | $9.3B | $9.5B | $8.4B | $8.3B | $8.2B |
| Shareholders' equity | $3.2B | $3.7B | $4.2B | $4.7B | $6.4B | $6.9B | $7.2B | $5.8B | $5.5B | $5.4B |
| Margins | ||||||||||
| Gross margin | 21.3% | 21.6% | 21.2% | 20.7% | 18.8% | 18.4% | 18.8% | 18.1% | 18.8% | 18.7% |
| Operating margin | 10.7% | 10.9% | 11.3% | 12.8% | 6.1% | 7.7% | 8.0% | 8.2% | 3.9% | 3.7% |
| EBITDA margin | 15.0% | 15.1% | 15.4% | 17.1% | 11.7% | 12.6% | 12.4% | 12.3% | 8.7% | 8.8% |
| Net margin | 6.6% | 4.5% | 8.8% | 7.3% | 4.9% | 4.6% | 7.5% | 4.4% | 2.4% | 1.9% |
| FCF margin | 5.9% | 6.3% | 5.5% | 5.2% | 7.3% | 6.7% | 7.5% | 4.0% | 5.1% | 8.2% |
| Returns | ||||||||||
| Return on capital | 12.8% | 10.4% | 17.7% | 14.1% | 4.9% | 8.6% | 7.9% | 8.9% | 5.4% | 4.6% |
| Return on capital employed | 14.3% | 15.2% | 15.8% | 17.3% | 6.3% | 7.3% | 7.9% | 9.9% | 5.2% | 5.2% |
| Return on equity | 17.6% | 12.7% | 23.4% | 16.7% | 9.0% | 8.0% | 13.3% | 9.6% | 6.0% | 5.1% |
| Return on assets | 6.6% | 4.7% | 9.4% | 7.5% | 3.9% | 3.3% | 5.6% | 4.0% | 2.4% | 2.0% |
| Growth | ||||||||||
| Revenue growth | 13.1% | 8.0% | 7.5% | β3.4% | β0.0% | 16.1% | 7.1% | 12.4% | β0.8% | 1.6% |
| Net income growth | 3.1% | β26.1% | 111.6% | β19.9% | β33.0% | 7.4% | 75.8% | β33.8% | β45.9% | β18.1% |
| EPS growth | 7.8% | β24.6% | 113.5% | β18.7% | β35.2% | β4.3% | 78.1% | β33.1% | β43.8% | β14.7% |
| FCF growth | 84.1% | 15.9% | β6.5% | β9.1% | 41.0% | 6.6% | 19.6% | β40.3% | 25.8% | 65.8% |
| Share count change | β4.6% | β1.8% | β1.0% | β1.3% | 3.5% | 11.9% | β1.1% | β1.0% | β4.1% | β3.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.2x | 1.1x | 0.8x | 0.6x | 1.8x | 1.6x | 1.8x | 1.3x | 1.7x | 1.3x |
| Debt / equity | 0.6x | 0.6x | 0.5x | 0.4x | 0.6x | 0.6x | 0.6x | 0.6x | 0.7x | 0.7x |
| Interest coverage | 11.5x | 15.1x | 20.2x | 23.7x | 8.5x | 11.2x | 14.2x | 15.9x | 6.5x | 5.4x |
| Current ratio | 1.4x | 1.5x | 1.6x | 1.7x | 1.6x | 1.7x | 1.6x | 1.7x | 1.8x | 2.1x |
| Quick ratio | 1.1x | 1.2x | 1.3x | 1.3x | 1.3x | 1.3x | 1.3x | 1.3x | 1.5x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.5% | 5.7% | 5.2% | 4.7% | 4.3% | 4.4% | 4.9% | 5.9% | 4.8% | 3.3% |
| Stock comp / revenue | 0.5% | 0.5% | 0.5% | 0.4% | 0.4% | 0.4% | 0.5% | 0.4% | 0.4% | 0.5% |
| Payouts / FCF | 75.0% | 36.1% | 50.3% | 45.5% | 48.7% | 20.5% | 42.3% | 54.3% | 70.3% | 53.2% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 8.0 | 7.0 | 6.0 | 4.0 | 5.0 | 8.0 | 7.0 | 7.0 | 7.0 |
| Altman Z'' | 3.5 | 3.7 | 4.2 | 5.0 | 3.3 | 3.6 | 3.6 | 3.8 | 3.8 | 4.2 |
| Accruals ratio | β4.9% | β8.0% | β2.0% | β2.7% | β5.3% | β4.7% | β3.7% | β4.9% | β7.3% | β9.9% |
Source: SEC EDGAR XBRL filings (CIK 0000908255). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.